Paradigm bought Deep Lens, the AI spinoff that uses genomics and EHR data to find oncology patients for clinical trials, as part of its launch.
Venture capital firms General Catalyst and Arch Venture Partners co-led the financing round, which also featured the American Cancer Society’s BrightEdge fund. General Catalyst’s Stephen Klasko, MD, a former health system leader, was named to Paradigm’s board.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
